LILRB4 and acute myeloid leukemia: To this end, Zhang’s group identified the second (Y412) and third (Y442) ITIMs of LILRB4 as those responsible for facilitating signaling in M-AML cells, specifically for inhibiting downstream T cell proliferation (82).